[1]
Alvarez-Lesmes J, Chapman JR, Cassidy D, Zhou Y, Garcia-Buitrago M, Montgomery EA, Lossos IS, Sussman D, Poveda J. Gastrointestinal Tract Lymphomas. Archives of pathology & laboratory medicine. 2021 Dec 1:145(12):1585-1596. doi: 10.5858/arpa.2020-0661-RA. Epub
[PubMed PMID: 33836528]
[2]
Vlăduţ C, Ciocîrlan M, Costache RS, Jinga M, Balaban VD, Costache DO, Diculescu M. Is mucosa-associated lymphoid tissue lymphoma an infectious disease? Role of Helicobacter pylori and eradication antibiotic therapy (Review). Experimental and therapeutic medicine. 2020 Oct:20(4):3546-3553. doi: 10.3892/etm.2020.9031. Epub 2020 Jul 23
[PubMed PMID: 32905014]
[3]
Ollila TA, Olszewski AJ. Extranodal Diffuse Large B Cell Lymphoma: Molecular Features, Prognosis, and Risk of Central Nervous System Recurrence. Current treatment options in oncology. 2018 Jun 21:19(8):38. doi: 10.1007/s11864-018-0555-8. Epub 2018 Jun 21
[PubMed PMID: 29931605]
[4]
Violeta Filip P, Cuciureanu D, Sorina Diaconu L, Maria Vladareanu A, Silvia Pop C. MALT lymphoma: epidemiology, clinical diagnosis and treatment. Journal of medicine and life. 2018 Jul-Sep:11(3):187-193. doi: 10.25122/jml-2018-0035. Epub
[PubMed PMID: 30364585]
[5]
Ikoma N, Badgwell BD, Mansfield PF. Multimodality Treatment of Gastric Lymphoma. The Surgical clinics of North America. 2017 Apr:97(2):405-420. doi: 10.1016/j.suc.2016.11.012. Epub 2017 Feb 14
[PubMed PMID: 28325194]
[6]
Perry C, Herishanu Y, Metzer U, Bairey O, Ruchlemer R, Trejo L, Naparstek E, Sapir EE, Polliack A. Diagnostic accuracy of PET/CT in patients with extranodal marginal zone MALT lymphoma. European journal of haematology. 2007 Sep:79(3):205-9
[PubMed PMID: 17662066]
[7]
Park JB, Koo JS. Helicobacter pylori infection in gastric mucosa-associated lymphoid tissue lymphoma. World journal of gastroenterology. 2014 Mar 21:20(11):2751-9. doi: 10.3748/wjg.v20.i11.2751. Epub
[PubMed PMID: 24659867]
[8]
Troppan K, Wenzl K, Neumeister P, Deutsch A. Molecular Pathogenesis of MALT Lymphoma. Gastroenterology research and practice. 2015:2015():102656. doi: 10.1155/2015/102656. Epub 2015 Apr 1
[PubMed PMID: 25922601]
[9]
Nakamura S, Matsumoto T. Helicobacter pylori and gastric mucosa-associated lymphoid tissue lymphoma: recent progress in pathogenesis and management. World journal of gastroenterology. 2013 Dec 7:19(45):8181-7. doi: 10.3748/wjg.v19.i45.8181. Epub
[PubMed PMID: 24363507]
[10]
Hirabayashi M, Traverse-Glehen A, Combes JD, Clifford GM, de Martel C. Estimating the prevalence of Epstein-Barr virus in primary gastric lymphoma: a systematic review and meta-analysis. Infectious agents and cancer. 2023 Feb 10:18(1):8. doi: 10.1186/s13027-023-00482-2. Epub 2023 Feb 10
[PubMed PMID: 36765388]
Level 1 (high-level) evidence
[11]
Juárez-Salcedo LM, Sokol L, Chavez JC, Dalia S. Primary Gastric Lymphoma, Epidemiology, Clinical Diagnosis, and Treatment. Cancer control : journal of the Moffitt Cancer Center. 2018 Jan-Mar:25(1):1073274818778256. doi: 10.1177/1073274818778256. Epub
[PubMed PMID: 29779412]
[12]
Peng JC, Zhong L, Ran ZH. Primary lymphomas in the gastrointestinal tract. Journal of digestive diseases. 2015 Apr:16(4):169-76. doi: 10.1111/1751-2980.12234. Epub
[PubMed PMID: 25678011]
[13]
Raderer M, Kiesewetter B, Ferreri AJ. Clinicopathologic characteristics and treatment of marginal zone lymphoma of mucosa-associated lymphoid tissue (MALT lymphoma). CA: a cancer journal for clinicians. 2016 Mar-Apr:66(2):153-71. doi: 10.3322/caac.21330. Epub 2015 Nov 24
[PubMed PMID: 26773441]
[14]
Foster LH, Portell CA. The role of infectious agents, antibiotics, and antiviral therapy in the treatment of extranodal marginal zone lymphoma and other low-grade lymphomas. Current treatment options in oncology. 2015 Jun:16(6):28. doi: 10.1007/s11864-015-0344-6. Epub
[PubMed PMID: 25975444]
[15]
Cogliatti SB, Griesser H, Peng H, Du MQ, Isaacson PG, Zimmermann DR, Maibach RC, Schmid U. Significantly different bcl-2 expression profiles in gastric and non-gastric primary extranodal high-grade B-cell lymphomas. The Journal of pathology. 2000 Dec:192(4):470-8
[PubMed PMID: 11113864]
[16]
Maeshima AM, Taniguchi H, Toyoda K, Yamauchi N, Makita S, Fukuhara S, Munakata W, Maruyama D, Kobayashi Y, Tobinai K. Clinicopathological features of histological transformation from extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue to diffuse large B-cell lymphoma: an analysis of 467 patients. British journal of haematology. 2016 Sep:174(6):923-31. doi: 10.1111/bjh.14153. Epub 2016 Jul 27
[PubMed PMID: 27460179]
[17]
Kiesewetter B, Lamm W, Dolak W, Lukas J, Mayerhoefer ME, Weber M, Schiefer AI, Kornauth C, Bayer G, Simonitsch-Klupp I, Raderer M. Transformed mucosa-associated lymphoid tissue lymphomas: A single institution retrospective study including polymerase chain reaction-based clonality analysis. British journal of haematology. 2019 Aug:186(3):448-459. doi: 10.1111/bjh.15953. Epub 2019 May 24
[PubMed PMID: 31124124]
Level 2 (mid-level) evidence
[18]
Connor J, Ashton-Key M. Gastric and intestinal diffuse large B-cell lymphomas are clinically and immunophenotypically different. An immunohistochemical and clinical study. Histopathology. 2007 Nov:51(5):697-703
[PubMed PMID: 17927592]
[19]
Hsi ED, Eisbruch A, Greenson JK, Singleton TP, Ross CW, Schnitzer B. Classification of primary gastric lymphomas according to histologic features. The American journal of surgical pathology. 1998 Jan:22(1):17-27
[PubMed PMID: 9422312]
[20]
Shirwaikar Thomas A, Schwartz M, Quigley E. Gastrointestinal lymphoma: the new mimic. BMJ open gastroenterology. 2019:6(1):e000320. doi: 10.1136/bmjgast-2019-000320. Epub 2019 Sep 13
[PubMed PMID: 31645987]
[21]
Ohkura Y, Lee S, Kaji D, Ota Y, Haruta S, Takeji Y, Shinohara H, Ueno M, Udagawa H. Spontaneous perforation of primary gastric malignant lymphoma: a case report and review of the literature. World journal of surgical oncology. 2015 Feb 8:13():35. doi: 10.1186/s12957-015-0458-0. Epub 2015 Feb 8
[PubMed PMID: 25889516]
Level 3 (low-level) evidence
[22]
Shimm DS, Dosoretz DE, Anderson T, Linggood RM, Harris NL, Wang CC. Primary gastric lymphoma. An analysis with emphasis on prognostic factors and radiation therapy. Cancer. 1983 Dec 1:52(11):2044-8
[PubMed PMID: 6627215]
[23]
Zullo A, Hassan C, Ridola L, Repici A, Manta R, Andriani A. Gastric MALT lymphoma: old and new insights. Annals of gastroenterology. 2014:27(1):27-33
[PubMed PMID: 24714739]
[24]
Püspök A, Raderer M, Chott A, Dragosics B, Gangl A, Schöfl R. Endoscopic ultrasound in the follow up and response assessment of patients with primary gastric lymphoma. Gut. 2002 Nov:51(5):691-4
[PubMed PMID: 12377808]
[25]
Pereira MI, Medeiros JA. Role of Helicobacter pylori in gastric mucosa-associated lymphoid tissue lymphomas. World journal of gastroenterology. 2014 Jan 21:20(3):684-98. doi: 10.3748/wjg.v20.i3.684. Epub
[PubMed PMID: 24574742]
[26]
Schizas D, Ntanasis-Stathopoulos I, Tsilimigras DI, Sioulas AD, Moris D, Spartalis E, Scotiniotis I, Papanikolaou IS. The Role of Endoscopic Ultrasound in the Diagnosis and Management of Primary Gastric Lymphoma. Gastroenterology research and practice. 2017:2017():2397430. doi: 10.1155/2017/2397430. Epub 2017 Mar 16
[PubMed PMID: 28400819]
[27]
Fuccio L, Laterza L, Zagari RM, Cennamo V, Grilli D, Bazzoli F. Treatment of Helicobacter pylori infection. BMJ (Clinical research ed.). 2008 Sep 15:337():a1454. doi: 10.1136/bmj.a1454. Epub 2008 Sep 15
[PubMed PMID: 18794181]
[28]
Fallone CA, Chiba N, van Zanten SV, Fischbach L, Gisbert JP, Hunt RH, Jones NL, Render C, Leontiadis GI, Moayyedi P, Marshall JK. The Toronto Consensus for the Treatment of Helicobacter pylori Infection in Adults. Gastroenterology. 2016 Jul:151(1):51-69.e14. doi: 10.1053/j.gastro.2016.04.006. Epub 2016 Apr 19
[PubMed PMID: 27102658]
Level 3 (low-level) evidence
[29]
Asano N, Iijima K, Koike T, Imatani A, Shimosegawa T. Helicobacter pylori-negative gastric mucosa-associated lymphoid tissue lymphomas: A review. World journal of gastroenterology. 2015 Jul 14:21(26):8014-20. doi: 10.3748/wjg.v21.i26.8014. Epub
[PubMed PMID: 26185372]
[30]
Greiner A, Knörr C, Qin Y, Sebald W, Schimpl A, Banchereau J, Müller-Hermelink HK. Low-grade B cell lymphomas of mucosa-associated lymphoid tissue (MALT-type) require CD40-mediated signaling and Th2-type cytokines for in vitro growth and differentiation. The American journal of pathology. 1997 May:150(5):1583-93
[PubMed PMID: 9137085]
Level 2 (mid-level) evidence
[31]
Stathis A, Chini C, Bertoni F, Proserpio I, Capella C, Mazzucchelli L, Pedrinis E, Cavalli F, Pinotti G, Zucca E. Long-term outcome following Helicobacter pylori eradication in a retrospective study of 105 patients with localized gastric marginal zone B-cell lymphoma of MALT type. Annals of oncology : official journal of the European Society for Medical Oncology. 2009 Jun:20(6):1086-93. doi: 10.1093/annonc/mdn760. Epub 2009 Feb 4
[PubMed PMID: 19193705]
Level 2 (mid-level) evidence
[32]
Nakamura S, Matsumoto T. Treatment Strategy for Gastric Mucosa-Associated Lymphoid Tissue Lymphoma. Gastroenterology clinics of North America. 2015 Sep:44(3):649-60. doi: 10.1016/j.gtc.2015.05.012. Epub 2015 Jun 23
[PubMed PMID: 26314674]
[33]
Chey WD, Leontiadis GI, Howden CW, Moss SF. ACG Clinical Guideline: Treatment of Helicobacter pylori Infection. The American journal of gastroenterology. 2017 Feb:112(2):212-239. doi: 10.1038/ajg.2016.563. Epub 2017 Jan 10
[PubMed PMID: 28071659]
[34]
Nieuwenburg SAV, Waddingham WW, Graham D, Rodriguez-Justo M, Biermann K, Kuipers EJ, Banks M, Jansen M, Spaander MCW. Accuracy of endoscopic staging and targeted biopsies for routine gastric intestinal metaplasia and gastric atrophy evaluation study protocol of a prospective, cohort study: the estimate study. BMJ open. 2019 Sep 18:9(9):e032013. doi: 10.1136/bmjopen-2019-032013. Epub 2019 Sep 18
[PubMed PMID: 31537576]
[35]
Rohatiner A, d'Amore F, Coiffier B, Crowther D, Gospodarowicz M, Isaacson P, Lister TA, Norton A, Salem P, Shipp M. Report on a workshop convened to discuss the pathological and staging classifications of gastrointestinal tract lymphoma. Annals of oncology : official journal of the European Society for Medical Oncology. 1994 May:5(5):397-400
[PubMed PMID: 8075046]
[36]
Ruskoné-Fourmestraux A, Dragosics B, Morgner A, Wotherspoon A, De Jong D. Paris staging system for primary gastrointestinal lymphomas. Gut. 2003 Jun:52(6):912-3
[PubMed PMID: 12740354]
[37]
Alderuccio JP, Reis IM, Habermann TM, Link BK, Thieblemont C, Conconi A, Larson MC, Cascione L, Zhao W, Cerhan JR, Zucca E, Lossos IS. Revised MALT-IPI: A new predictive model that identifies high-risk patients with extranodal marginal zone lymphoma. American journal of hematology. 2022 Dec:97(12):1529-1537. doi: 10.1002/ajh.26715. Epub 2022 Sep 19
[PubMed PMID: 36057138]
[38]
Nakamura S, Matsumoto T, Nakamura S, Jo Y, Fujisawa K, Suekane H, Yao T, Tsuneyoshi M, Iida M. Chromosomal translocation t(11;18)(q21;q21) in gastrointestinal mucosa associated lymphoid tissue lymphoma. Journal of clinical pathology. 2003 Jan:56(1):36-42
[PubMed PMID: 12499431]